All Updates

All Updates

icon
Filter
Partnerships
Ultima Genomics and Genome Insight to bring low-cost whole-genome sequencing to cancer patients
Precision Medicine
Apr 10, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 10, 2023

Ultima Genomics and Genome Insight to bring low-cost whole-genome sequencing to cancer patients

Partnerships

  • Gene sequencer and software platform provider Ultima Genomics has partnered with bioinformatics startup Genome Insight to bring affordable whole-genome sequencing solutions to cancer patients. 

  • Genome Insight will join the early access program for Ultima's high-throughput next-generation sequencing (NGS) instrument platform, the UG 100, and optimize its whole-genome bioinformatics solution for Ultima's sequencing technology. By combining Genome Insight's proprietary bioinformatics with Ultima's low-cost sequencing, whole-genome sequencing will become an affordable option for cancer patients. This approach will enable the delivery of curated whole-genome sequencing reports to patients and physicians at a lower cost than conventional NGS panels.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.